Quick Answer
HUTCHMED (China) Ltd reported Operating Income Loss of -$39.16 million for the year ending 2025.
- HUTCHMED (China) Ltd showed an increase of +10.4% in Operating Income Loss from 2024 to 2025.
- This data is from HUTCHMED (China) Ltd's annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), HUTCHMED (China) Ltd's Operating Income Loss has declined by 114.5%.
- Historical annual values: Fiscal year 2025: -$39.16 million | Fiscal year 2024: -$43.71 million | Fiscal year 2023: $18.38 million | Fiscal year 2022: -$407.69 million | Fiscal year 2021: -$328.32 million | Fiscal year 2020: -$196.67 million | Fiscal year 2019: -$146.39 million | Fiscal year 2018: -$92.64 million | Fiscal year 2017: -$53.42 million | Fiscal year 2016: -$46.70 million | Fiscal year 2015: -$9.77 million | Fiscal year 2014: -$18.26 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: